new scientist excellent article conflict interest involving called grassroots patient organizations receive drug company funding support i like thank reader site provided me link story long excerpts emphasis supposed grassroots organisations representing interests people serious diseases drummond rennie professor medicine university california san francisco deputy editor journal american medical association believes patient groups perilously close becoming extensions pharmaceutical companies marketing departments crisis contends rather grassroots word rennie uses describe organisations astroturf originating black arts politics public relations astroturfing practice disguising orchestrated campaign spontaneous upwelling public opinion health specialists go far still uneasy financial relationships drug firms prominent patient groups i think grounds concerned says joel lexchin studies pharmaceutical policy york university toronto canada others point instances representatives patient groups sometimes close contact corporate public relations teams spoken favourably drugs meetings press conferences charge astroturfing fair much money patient groups typically taking pharmaceutical medical device firms affect behaviour investigate new scientist conducted largest survey date industry donations patient groups based biggest single market drugs medical devices well taking random sample identified groups associated conditions companies accused disease mongering encouraging expansion boundaries illness order boost sales treatment see groups selected though allegations unproven decided important investigate whether patient groups received unusually large proportions funding industry case tried determine percentage group total funding came pharmaceutical medical device industry recent year figures available always easy non profit organisations required law disclose donors identities tax returns annual reports provided information cases obtaining figure required group concerned provide voluntarily extent industry funding varied widely see chart right cases cash amounts enormous million case american heart association largest organisation studied although accounted per cent total funding small proportions funding may cause concern lexchin says unless go toward activities like creating biased treatment information depends money used lexchin also believes need greater transparency donations coming patients evaluate information groups providing total seven groups received per cent funding pharmaceutical medical device companies including four linked conditions accusations disease mongering made one groups depression bipolar support alliance said received half funding industry group provide exact percentage combined information annual report tax return reveals per cent revenue came major donors drug device companies restless legs syndrome rls foundation instance received million revenue glaxosmithkline gsk nearly boehringer ingelheim gsk drug requip approved syndrome boehringer ingelheim drug pending fda approval drugs intended control symptoms rls long periods symptoms seriously disturb sleep critics claim prevalence exaggerated gsk media reports extent industry funding rls foundation pretty incredible says one critic steve woloshin dartmouth medical school hanover new hampshire however rls foundation gsk reject accusations disease mongering gsk clear requip indicated moderate severe rls says company spokeswoman holly russell main sense get patients enormous sense relief adds show me scientific article says people condition people mild rls flocking take drugs says georgianna bell executive director rls foundation contrast groups survey received industry funding seemed diseases drug companies little opportunity profit example people supported faces national craniofacial association typically treated surgery ehlers danlos national foundation people disorder body connective tissue specific treatment amyotrophic lateral sclerosis association received per cent million budget pharmaceutical companies neurodegenerative disease typically fatal within four years diagnosis one drug approved food drug administration treat aventis manufactures drug provided association timing donations also suggests link marketing interests though donations individual groups vary year year various reasons pfizer example major donor rls foundation july firm announced ceased developing candidate rls drug following year donations patient group ceased meanwhile concerns safety psychiatric drugs children reached new heights hit child adolescent bipolar foundation hard donations industry fell per cent total revenue per cent pharmaceutical companies willing support increased scrutiny around psychiatric treatments children says susan resko foundation executive director consequence lay half staff information websites groups survey raises questions example treatment section depression bipolar support alliance site developed educational grant neuronetics company gave least possibly much alliance one page describes transcranial magnetic stimulation tms vagus nerve stimulation vns aim treat mood disorders stimulating neural activity neuronetics makes equipment tms yet approved treatment nevertheless site provides web links telephone numbers neuronetics cyberonics vns equipment maker donated alliance read whole story view i certain nearly always starts innocuously group wants support people condition starts humbly scraping scarce resources together truly grassroots effort company notices group needs money know people individuals groups often money belief patient groups truly believe influenced drug company funding perusing websites hard believe true influence completely subconscious i write depression bipolar support alliance soon link another good story requip restless legs issue